Compare ASIC & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASIC | TLRY |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | 203 | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.6M | 688.9M |
| IPO Year | N/A | 2018 |
| Metric | ASIC | TLRY |
|---|---|---|
| Price | $19.86 | $5.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $26.75 | ★ $72.33 |
| AVG Volume (30 Days) | 63.0K | ★ 7.0M |
| Earning Date | 04-29-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.21 | $8.79 |
| Revenue Next Year | $34.65 | $19.98 |
| P/E Ratio | $98.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.35 | $0.36 |
| 52 Week High | $23.88 | $15.70 |
| Indicator | ASIC | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 32.23 |
| Support Level | $17.16 | $1.12 |
| Resistance Level | $21.21 | $7.01 |
| Average True Range (ATR) | 1.01 | 0.25 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 27.96 | 4.99 |
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.